185 related articles for article (PubMed ID: 11329795)
1. [Tumor markers for endocrine neoplasms].
Okamoto T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid carcinoma].
Tamaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
[TBL] [Abstract][Full Text] [Related]
3. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
[TBL] [Abstract][Full Text] [Related]
4. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Carmignani F; Piscopello L; Sammartini C
Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
6. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
Gerardi G; De Angelis P
Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
[TBL] [Abstract][Full Text] [Related]
7. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers for thyroid malignant disease].
Tamura K
Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
[No Abstract] [Full Text] [Related]
9. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
10. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
11. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
12. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
[TBL] [Abstract][Full Text] [Related]
13. [Biological investigation of thyroid cancer].
Douik H; Ghanem A; Jmal A; Harzallah L; Gara S; Abdennebi M; Boussen H; Guemira F
Tunis Med; 2006 Mar; 84(3):135-41. PubMed ID: 16755952
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
[TBL] [Abstract][Full Text] [Related]
15. [The differential diagnosis of thyroid cancer using radioimmunologic analysis].
Ametov AS; Voronetskiĭ IB; Ol'shanskiĭ VO; Toritsyna LK; Larina IM
Med Radiol (Mosk); 1990 Feb; 35(2):11-4. PubMed ID: 2314197
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Kavishwar VS; Phatak AM; Rege JD
Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
18. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
19. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
20. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
Hennemann G; Hennemann IP; Docter R; Krenning EP
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
[No Abstract] [Full Text] [Related]
[Next] [New Search]